Poster Abstracts
Jeffrey D. Bower, Ph.D.
VP Analytics
Sana Health
Boulder, Colorado
Martin Cheatle, Ph.D.
Associate Professor of Psychiatry
Perelman School of Medicine, University of Pennsylvania
Perelman School of Medicine, University of Pennsylvania
Philadelphia, Pennsylvania
Marc Robberson, MA
Director Clinical Operations
Sana Health
Louisville, Colorado
Richard Hanbury, MBA
CEO
Sana Health
Louisville, Colorado
The effectiveness of a novel Audio-Visual-Stimulation Device for improving symptoms and quality of life in fibromyalgia; a fully remote large-scale trial
Background:
Fibromyalgia (FM) is associated with widespread chronic pain as well as additional symptoms including fatigue, sleep disturbances (Clauw, 2014), and mood disturbances (Brito, 2018). The inter-relation of symptoms of pain, poor quality sleep, mood disorders, and fatigue lead to poor quality of life for patients with FM (Jacobs, 2020).
Purpose/Objectives:
In this open label fully-remote study we assessed the effectiveness a novel Audio Visual Stimulation (AVS) improving Quality of Life (QOL) and symptoms of FM in a real-world setting.
Method:
A cohort of 227 participants with FM used the novel AVS device for 28 days. Outcomes examined were; Fibromyalgia Impact Questionnaire – Revised (FIQ-R), Patient Global Impression of Change (PGIC), General Anxiety Disorder 7 (GAD-7), Patient Health Questionnaire 8 (PHQ-8), Promis 8a Sleep Disturbance Scale (PR8A), Pain-Enjoyment-General-Activity scale (PEG), Pain Catastrophizing Scale (PCS), as well as medication and healthcare usage surveys.
Results:
From Baseline to end of treatment there were improvements in FM symptoms (FIQ-R, p < = 0.001), quality of life (PGIC, p < = 0.001), anxiety (GAD-7, p < = 0.001), depression (PHQ-8, p < = 0.001), sleep (PR8A, p < = 0.001), and pain (PEG, p < = 0.001; PCS, p < = 0.001). In addition, medication usage decreased by 24% (95%CI, 19-29%) and healthcare visits decreased by 10% (95%CI, 7-15%)
Conclusions: FM is a common pain disorder that leads to significant suffering. This pilot study demonstrates the effectiveness of a novel, safe AVS device in improving QOL, symptoms, pain, sleep, mood, as well as reducing medication usage and health care visits.
References: Clauw D. J. (2014). Fibromyalgia: a clinical review. JAMA, 311(15), 1547–1555. https://doi.org/10.1001/jama.2014.3266
Brito, R., Santos, P., Oliveira, Pina, L., Antoniolli, A., Almeida, J., Picot, L. Zengin, G. & Quintans, J., Quintans-Júnior, L. (2018). Natural Products as Promising Pharmacological Tools for the Management of Fibromyalgia Symptoms – A Review. (pp. 57-78). Intech. http://dx.doi.org/10.5772/intechopen.70016
Jacobs, H., Bockaert, M., Bonte, J., D'Haese, M., Degrande, J., Descamps, L., ... & De Bacquer, D. (2020). The impact of a group-based multidisciplinary rehabilitation program on the quality of life in patients with fibromyalgia: results from the QUALIFIBRO Study. JCR: Journal of Clinical Rheumatology, 26(8), 313-319.